Thomas Folinsbee

Director/Board Member at CASI PHARMACEUTICALS, INC.

Net worth: - $ as of 31/03/2026

59 year

89 connections

Health Technology

Finance

Consumer Services

Profile

Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CASI PHARMACEUTICALS, INC. -.--%	30/04/2026	0 ( -.--% )	- $	31/03/2026

Thomas Folinsbee active positions

Companies	Position	Start
CASI PHARMACEUTICALS, INC.	Director/Board Member	21/03/2023
Shanghai Alebund Pharmaceuticals Ltd.	Corporate Officer/Principal	01/01/2019

All active positions of Thomas Folinsbee

Former positions of Thomas Folinsbee

Companies	Position	End
Bison Capital Acquisition Corp. Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company	Director/Board Member	01/01/2019
3SBIO INC.	Corporate Officer/Principal	01/01/2019
Hisanaga Seisakusho Co. Ltd.	Director/Board Member	01/01/2016
SUMT HEAL	Director/Board Member	-
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.	Director/Board Member	-

See the detail of Thomas Folinsbee's experience

Training of Thomas Folinsbee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Folinsbee's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
3SBio, Inc. 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products	Health Technology
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hisanaga Seisakusho Co. Ltd.
Bison Capital Acquisition Corp. Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company	Finance
Xynomic Pharmaceuticals Holdings, Inc. Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs	Health Technology
Summit Healthcare Acquisition Corp. Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Shanghai Alebund Pharmaceuticals Ltd.
CASI Pharmaceuticals, Inc. CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products	Health Technology